Genscript Biotech Corp (GNNSF)
1.47
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Genscript Biotech Price to Book Value: 2.244 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.244 |
| May 02, 2024 | 2.244 |
| May 01, 2024 | 2.244 |
| April 30, 2024 | 2.306 |
| April 29, 2024 | 2.306 |
| April 26, 2024 | 2.290 |
| April 25, 2024 | 2.290 |
| April 24, 2024 | 2.290 |
| April 23, 2024 | 2.290 |
| April 22, 2024 | 2.290 |
| April 19, 2024 | 2.290 |
| April 18, 2024 | 2.290 |
| April 17, 2024 | 2.336 |
| April 16, 2024 | 2.336 |
| April 15, 2024 | 3.054 |
| April 12, 2024 | 3.054 |
| April 11, 2024 | 3.054 |
| April 10, 2024 | 3.054 |
| April 09, 2024 | 3.054 |
| April 08, 2024 | 3.054 |
| April 05, 2024 | 3.054 |
| April 04, 2024 | 3.054 |
| April 03, 2024 | 3.054 |
| April 02, 2024 | 3.054 |
| April 01, 2024 | 3.054 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.054 |
| March 27, 2024 | 3.054 |
| March 26, 2024 | 3.054 |
| March 25, 2024 | 3.054 |
| March 22, 2024 | 3.049 |
| March 21, 2024 | 3.049 |
| March 20, 2024 | 3.049 |
| March 19, 2024 | 3.049 |
| March 18, 2024 | 3.125 |
| March 15, 2024 | 3.125 |
| March 14, 2024 | 3.125 |
| March 13, 2024 | 3.125 |
| March 12, 2024 | 3.125 |
| March 11, 2024 | 3.037 |
| March 08, 2024 | 3.037 |
| March 07, 2024 | 3.037 |
| March 06, 2024 | 3.037 |
| March 05, 2024 | 3.037 |
| March 04, 2024 | 3.037 |
| March 01, 2024 | 3.037 |
| February 29, 2024 | 3.037 |
| February 28, 2024 | 3.037 |
| February 27, 2024 | 2.668 |
| February 26, 2024 | 2.668 |
| February 23, 2024 | 2.668 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.244
Minimum
May 01 2024
12.18
Maximum
Feb 06 2020
6.493
Average
6.414
Median
Feb 10 2023
Price to Book Value Benchmarks
| Sinovac Biotech Ltd | 0.074 |
| CASI Pharmaceuticals Inc | 1.55 |
| Zai Lab Ltd | 2.025 |
| I-MAB | 0.5873 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.694 |
| Price | 1.47 |
| Earnings Yield | -3.08% |
| Market Cap | 3.122B |